Late onset sporadic Parkinson's disease caused by PINK1 mutations: clinical and functional study
- PMID: 18307263
- DOI: 10.1002/mds.21960
Late onset sporadic Parkinson's disease caused by PINK1 mutations: clinical and functional study
Abstract
Homozygous or compound heterozygous mutations in the PINK1 gene represent the second most frequent cause of autosomal recessive parkinsonism after Parkin. The phenotype differs from idiopathic Parkinson's disease for earlier onset, slower disease progression, and better response to therapy. Indeed, the rare patients with onset above 50 years are usually relatives of early-onset probands. Here, we report the first occurrence of compound heterozygous PINK1 mutations in a sporadic patient with a phenotype indistinguishable from idiopathic Parkinson's disease (PD), with onset in the late seventh decade, rapid progression and good response to levodopa that waned with time. Both mutations (p.A244G and p.V317I) were found to abolish the protective effect of wild-type PINK1 against staurosporine-induced apoptosis. These findings further expand the clinical spectrum of PINK1-related parkinsonism to include late onset, typical PD, and underline the existing difficulties in discriminating between mendelian parkinsonism and idiopathic PD.
(c) 2008 Movement Disorder Society.
Similar articles
-
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.Brain. 2006 Mar;129(Pt 3):686-94. doi: 10.1093/brain/awl005. Epub 2006 Jan 9. Brain. 2006. PMID: 16401616
-
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47. BMC Neurol. 2008. PMID: 19087301 Free PMC article.
-
Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.BMC Neurol. 2017 Aug 8;17(1):153. doi: 10.1186/s12883-017-0933-z. BMC Neurol. 2017. PMID: 28789629 Free PMC article.
-
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.Lancet Neurol. 2007 Jul;6(7):652-62. doi: 10.1016/S1474-4422(07)70174-6. Lancet Neurol. 2007. PMID: 17582365 Review.
-
Autosomal recessive parkinsonism.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S4-6. doi: 10.1016/S1353-8020(11)70004-9. Parkinsonism Relat Disord. 2012. PMID: 22166450 Review.
Cited by
-
PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage.Cells. 2022 Feb 15;11(4):678. doi: 10.3390/cells11040678. Cells. 2022. PMID: 35203326 Free PMC article.
-
Parkinson's disease as a result of aging.Aging Cell. 2015 Jun;14(3):293-308. doi: 10.1111/acel.12312. Epub 2015 Feb 9. Aging Cell. 2015. PMID: 25677794 Free PMC article. Review.
-
The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.Int J Biochem Cell Biol. 2009 Oct;41(10):2025-35. doi: 10.1016/j.biocel.2009.02.018. Epub 2009 Mar 5. Int J Biochem Cell Biol. 2009. PMID: 19703660 Free PMC article. Review.
-
Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons.Front Aging Neurosci. 2024 Sep 18;16:1451655. doi: 10.3389/fnagi.2024.1451655. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39364348 Free PMC article. Review.
-
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.Hum Mutat. 2010 Jul;31(7):763-80. doi: 10.1002/humu.21277. Hum Mutat. 2010. PMID: 20506312 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources